---
document_datetime: 2023-09-21 20:59:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aptivus-epar-all-authorised-presentations_en.pdf
document_name: aptivus-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2643645
conversion_datetime: 2025-12-30 11:52:20.38485
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical   | Route of       | Immediate     | Content         | Pack size    |
|------------------|--------------|------------|------------------|----------------|---------------|-----------------|--------------|
|                  | name         |            | form             | administration | packaging     | (concentration) |              |
| EU/1/05/315/001  | Aptivus      | 250 mg     | Capsule, soft    | Oral use       | bottle (HDPE) |                 | 120 capsules |